Qube Research & Technologies (QRT)’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-114,335	Closed	-$5.31M	–	4412
2023 Q2	$5.31M	Buy	+114,335	New	+$3.95M	0.02%	689
2022 Q3	–	Sell	-17,903	Closed	-$278K	–	3202
2022 Q2	$278K	Buy	+17,903	New	+$308K	﹤0.01%	1614
2021 Q4	–	Sell	-6,788	Closed	-$222K	–	3109
2021 Q3	$222K	Buy	+6,788	New	+$231K	﹤0.01%	1614

Qube Research & Technologies (QRT)'s DICE Position: Q3 2023 in Review

Qube Research & Technologies (QRT) sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 114,335 shares — an estimated $5.31M sold.

Qube Research & Technologies (QRT) first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $5.31M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Qube Research & Technologies (QRT) reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 114,335 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $5.31M.
Qube Research & Technologies (QRT) first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Qube Research & Technologies (QRT)'s DICE Therapeutics, Inc. Common Stock position peaked at $5.31M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.